169 related articles for article (PubMed ID: 16269020)
1. Four peptide hormones' specific decrease (up to 97%) of human prostate carcinoma cells.
Vesely BA; Alli AA; Song SJ; Gower WR; Sanchez-Ramos J; Vesely DL
Eur J Clin Invest; 2005 Nov; 35(11):700-10. PubMed ID: 16269020
[TBL] [Abstract][Full Text] [Related]
2. Four peptide hormones decrease the number of human breast adenocarcinoma cells.
Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Solivan SM; Gower WR; Vesely DL
Eur J Clin Invest; 2005 Jan; 35(1):60-9. PubMed ID: 15638821
[TBL] [Abstract][Full Text] [Related]
3. Five cardiac hormones decrease the number of human small-cell lung cancer cells.
Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Alli AA; Solivan SM; Gower WR; Vesely DL
Eur J Clin Invest; 2005 Jun; 35(6):388-98. PubMed ID: 15948900
[TBL] [Abstract][Full Text] [Related]
4. Novel therapeutic approach for cancer using four cardiovascular hormones.
Vesely DL; Clark LC; Garces AH; McAfee QW; Soto J; Gower WR
Eur J Clin Invest; 2004 Oct; 34(10):674-82. PubMed ID: 15473892
[TBL] [Abstract][Full Text] [Related]
5. Urodilatin and four cardiac hormones decrease human renal carcinoma cell numbers.
Vesely BA; Eichelbaum EJ; Alli AA; Sun Y; Gower WR; Vesely DL
Eur J Clin Invest; 2006 Nov; 36(11):810-9. PubMed ID: 17032349
[TBL] [Abstract][Full Text] [Related]
6. Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice.
Vesely DL; Vesely BA; Eichelbaum EJ; Sun Y; Alli AA; Gower WR
In Vivo; 2007; 21(6):973-8. PubMed ID: 18210743
[TBL] [Abstract][Full Text] [Related]
7. Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones.
Vesely DL; Eichelbaum EJ; Sun Y; Alli AA; Vesely BA; Luther SL; Gower WR
In Vivo; 2007; 21(3):445-51. PubMed ID: 17591353
[TBL] [Abstract][Full Text] [Related]
8. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
Vesely DL
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
[TBL] [Abstract][Full Text] [Related]
9. Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Wang H; Vesely DL
Anticancer Res; 2007; 27(3B):1387-92. PubMed ID: 17595752
[TBL] [Abstract][Full Text] [Related]
10. Cardiac hormones inhibit proliferation of pancreatic cancer but not normal cells.
Skelton WP; Pi G; Lenz A; Sun Y; Vesely DL
Eur J Clin Invest; 2010 Aug; 40(8):706-12. PubMed ID: 20546014
[TBL] [Abstract][Full Text] [Related]
11. Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Skelton WP; Lenz A; Wang H; Vesely DL
Anticancer Res; 2009 Apr; 29(4):971-5. PubMed ID: 19414334
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical localization of atrial natriuretic peptide, vessel dilator, long-acting natriuretic peptide, and kaliuretic peptide in human pancreatic adenocarcinomas.
Saba SR; Garces AH; Clark LC; Soto J; Gower WR; Vesely DL
J Histochem Cytochem; 2005 Aug; 53(8):989-95. PubMed ID: 15879575
[TBL] [Abstract][Full Text] [Related]
13. Vessel dilator and kaliuretic peptide inhibit ERK 1/2 activation in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Wang H; Vesely DL
Anticancer Res; 2006; 26(5A):3217-22. PubMed ID: 17094432
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor's activation of Ras is inhibited by four cardiac hormones.
Sun Y; Eichelbaum EJ; Lenz A; Wang H; Vesely DL
Eur J Clin Invest; 2010 May; 40(5):408-13. PubMed ID: 20353436
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic peptide and long-acting natriuretic peptide inhibit ras in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Lenz A; Skelton WP; Wang H; Vesely DL
Anticancer Res; 2009 Jun; 29(6):1889-93. PubMed ID: 19528444
[TBL] [Abstract][Full Text] [Related]
16. Cardiac hormones eliminate some human squamous lung carcinomas in athymic mice.
Lenz A; Sun Y; Eichelbaum EJ; Skelton WP; Pi G; Vesely DL
Eur J Clin Invest; 2010 Mar; 40(3):242-9. PubMed ID: 20415699
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide attenuates hypoxia induced chemoresistance in prostate cancer cells.
Bell EN; Tse MY; Frederiksen LJ; Gardhouse A; Pang SC; Graham CH; Siemens DR
J Urol; 2007 Feb; 177(2):751-6. PubMed ID: 17222675
[TBL] [Abstract][Full Text] [Related]
18. Vessel dilator: most potent of the atrial natriuretic peptides in decreasing the number and DNA synthesis of human squamous lung cancer cells.
Vesely BA; Fitz SR; Gower WR; Vesely DL
Cancer Lett; 2006 Feb; 233(2):226-31. PubMed ID: 15893414
[TBL] [Abstract][Full Text] [Related]
19. Four cardiac hormones cause death of human cancer cells but not of healthy cells.
Skelton WP; Pi GE; Vesely DL
Anticancer Res; 2011 Feb; 31(2):395-402. PubMed ID: 21378317
[TBL] [Abstract][Full Text] [Related]
20. Cardiac and kidney hormones cure up to 86% of human small-cell lung cancers in mice.
Eichelbaum EJ; Sun Y; Alli AA; Gower WR; Vesely DL
Eur J Clin Invest; 2008 Aug; 38(8):562-70. PubMed ID: 18717826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
